{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:33:17Z","timestamp":1787614397068,"version":"build-2736575974"},"reference-count":32,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Natural Science Foundation of Guangdong Province of China","award":["2025A1515012635"],"award-info":[{"award-number":["2025A1515012635"]}]},{"name":"Beijing Public Health Foundation","award":["QYJJ-QNXZ-23"],"award-info":[{"award-number":["QYJJ-QNXZ-23"]}]},{"award":["QYJJ-QNXZ-23"],"award-info":[{"award-number":["QYJJ-QNXZ-23"]}],"id":[{"id":"https:\/\/ror.org\/02zmc3h95","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Reliable axillary restaging after neoadjuvant chemotherapy (NAC) is essential for patients with initially cN1 breast cancer considered for surgical de-escalation. Although radioisotope plus blue dye dual-tracer mapping can reduce the false-negative rate (FNR) of sentinel lymph node biopsy (SLNB), its routine use is limited by radioisotope access, infrastructure requirements, and procedural complexity. We evaluated contrast-enhanced ultrasound (CEUS) combined with methylene blue as a non-radioactive dual-mapping strategy. Methods: In this two-center prospective cohort study, patients undergoing surgery after NAC were enrolled if they received preoperative CEUS, intraoperative methylene blue mapping, SLNB, and axillary lymph node dissection. The primary analysis focused on patients with initially cN1 disease, whereas cN2\u20133 patients were included only for exploratory analyses. Detection rate (DR), FNR, predictive values, CEUS\u2013methylene blue concordance, and CEUS performance for predicting SLN metastasis were assessed. Results: A total of 269 patients were enrolled, including 208 with initial cN1 disease, 45 with cN2 disease, and 16 with cN3 disease. In the cN1 cohort, CEUS plus methylene blue achieved the highest SLN DR (99.04%; 95% CI, 96.56\u201399.74), followed by CEUS alone (98.08%) and methylene blue alone (71.63%). The FNR was 9.38% (95% CI, 4.37\u201318.98) for both CEUS plus methylene blue and CEUS alone, versus 12.50% for methylene blue alone. CEUS\u2013methylene blue concordance was 91.16%. For predicting SLN metastasis, CEUS showed 65.52% sensitivity, 86.30% specificity, and 80.39% accuracy. No immediate procedure-related adverse events occurred. Conclusions: CEUS combined with methylene blue showed high SLN detection and a promising false-negative profile in patients with initially cN1 breast cancer after NAC. These findings support further evaluation of this feasible non-radioactive strategy with larger comparative studies, particularly in settings with limited access to radioisotope-guided mapping.<\/jats:p>","DOI":"10.3390\/cancers18152383","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T07:36:13Z","timestamp":1784878573000},"page":"2383","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Contrast-Enhanced Ultrasound Combined with Methylene Blue for Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients with Initially cN1 Breast Cancer: A Multicenter Prospective Cohort Study"],"prefix":"10.3390","volume":"18","author":[{"given":"Duanyang","family":"Zhai","sequence":"first","affiliation":[{"name":"Department of Breast Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyun","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjian","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NiJiati","family":"AiErken","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawei","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6032-0442","authenticated-orcid":false,"given":"Yanling","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Shan","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1200\/JCO.2003.12.005","article-title":"The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: Preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27","volume":"21","author":"Bear","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/SLA.0000000000001417","article-title":"Impact of neoadjuvant chemotherapy in stage II\u2013III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates","volume":"262","author":"Golshan","year":"2015","journal-title":"Ann. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1200\/JCO.2005.05.188","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: Results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27","volume":"23","author":"Mamounas","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1001\/jamaoncol.2021.4394","article-title":"Nodal recurrence in patients with node-positive breast cancer treated with sentinel node biopsy alone after neoadjuvant chemotherapy: A rare event","volume":"7","author":"Barrio","year":"2021","journal-title":"JAMA Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/jamaoncol.2024.0578","article-title":"Omission of axillary dissection following nodal downstaging with neoadjuvant chemotherapy","volume":"10","author":"Montagna","year":"2024","journal-title":"JAMA Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Tinterri, C., Barbieri, E., Sagona, A., Di Maria Grimaldi, S., and Gentile, D. (2024). De-escalation of axillary surgery in clinically node-positive breast cancer patients treated with neoadjuvant therapy: Comparative long-term outcomes of sentinel lymph node biopsy versus axillary lymph node dissection. Cancers, 16.","DOI":"10.3390\/cancers16183168"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Yoneto, T., Ikiuo, F., Koyanagi, N., Yoshimoto, T., and Takeda, Y. (2025). Sentinel lymph node biopsy predicts non-sentinel lymph node metastases and supports omission of axillary lymph node dissection in breast cancer patients. J. Clin. Med., 14.","DOI":"10.3390\/jcm14103441"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: Overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","article-title":"A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer","volume":"349","author":"Veronesi","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: The ACOSOG Z1071 trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): A prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.breast.2021.07.015","article-title":"Feasibility and reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with positive axillary nodes at initial diagnosis: An up-to-date meta-analysis of 3,578 patients","volume":"59","author":"Cao","year":"2021","journal-title":"Breast"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: The SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","article-title":"Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer who receive neoadjuvant chemotherapy","volume":"263","author":"Boughey","year":"2016","journal-title":"Ann. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes","volume":"34","author":"Caudle","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/jamasurg.2022.3907","article-title":"Diagnostic accuracy of radioactive iodine seed placement in the axilla with sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer","volume":"157","author":"Simons","year":"2022","journal-title":"JAMA Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jamasurg.2023.1772","article-title":"Safety of targeted axillary dissection after neoadjuvant therapy in patients with node-positive breast cancer","volume":"158","author":"Kuemmel","year":"2023","journal-title":"JAMA Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1097\/SLA.0000000000004572","article-title":"A prospective, multicenter registry study to evaluate the clinical feasibility of targeted axillary dissection in node-positive breast cancer patients","volume":"276","author":"Kuemmel","year":"2022","journal-title":"Ann. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Heidinger, M., and Weber, W.P. (2024). Axillary surgery for breast cancer in 2024. Cancers, 16.","DOI":"10.3390\/cancers16091623"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1016\/S1470-2045(13)70590-4","article-title":"Novel techniques for sentinel lymph node biopsy in breast cancer: A systematic review","volume":"15","author":"Ahmed","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.crad.2017.06.121","article-title":"Preoperative sentinel lymph node identification, biopsy and localisation using contrast-enhanced ultrasound in patients with breast cancer: A systematic review and meta-analysis","volume":"72","author":"Bull","year":"2017","journal-title":"Clin. Radiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.21037\/qims-22-234","article-title":"Ultrasound contrast-enhanced patterns of sentinel lymph nodes: Predictive value for nodal status and metastatic burden in early breast cancer","volume":"13","author":"Zhu","year":"2023","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zhu, Y., Fan, X., Yang, D., Dong, T., Jia, Y., and Nie, F. (2021). Contrast-enhanced ultrasound for precise sentinel lymph node biopsy in women with early breast cancer: A preliminary study. Diagnostics, 11.","DOI":"10.3390\/diagnostics11112104"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/jum.16164","article-title":"Sentinel lymph node identification in post-neoadjuvant chemotherapy breast cancer patients undergoing surgical excision using lymphosonography","volume":"42","author":"Machado","year":"2023","journal-title":"J. Ultrasound Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00404-020-05646-8","article-title":"Contrast-enhanced ultrasonography and blue dye methods in detection of sentinel lymph nodes following neoadjuvant chemotherapy in initially node-positive breast cancer","volume":"302","author":"Wu","year":"2020","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Zhong, J., Luo, J., Li, J., Li, M., Liu, Y., Liang, J., Pan, F., Xie, X., and Zheng, Y. (2025). The diagnostic value of multimodal contrast-enhanced ultrasound in sentinel lymph nodes after neoadjuvant therapy for breast cancer. Diagnostics, 15.","DOI":"10.3390\/diagnostics15192432"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1159\/000543662","article-title":"Long-term survival of node-positive breast cancer with complete nodal response to neoadjuvant chemotherapy treated with sentinel lymph node biopsy alone: A meta-analysis","volume":"103","author":"Ding","year":"2025","journal-title":"Oncology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s12282-025-01692-9","article-title":"Different strategies in de-escalation of axillary surgery in node-positive breast cancer following neoadjuvant treatment: A systematic review and meta-analysis of long-term outcomes","volume":"32","author":"Man","year":"2025","journal-title":"Breast Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Cetinkaya, G., Bahcecioglu, I.B., Horasan, S., Bardakci, O., and Gulcelik, M.A. (2025). Ghost in the axilla: Luminal-type breast cancer and occult sentinel node metastasis after neoadjuvant chemotherapy. J. Clin. Med., 14.","DOI":"10.3390\/jcm14248658"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Cebrecos, I., Torras, I., Castillo, H., Pumarola, C., Ganau, S., Sitges, C., Vidal-Sicart, S., Schettini, F., Sanfeliu, E., and Loinaz, I. (2024). Predicting additional metastases in axillary lymph node dissection after neoadjuvant chemotherapy: Ratio of positive\/total sentinel nodes. Cancers, 16.","DOI":"10.3390\/cancers16213638"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/15\/2383\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T07:45:51Z","timestamp":1784879151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/15\/2383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":32,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["cancers18152383"],"URL":"https:\/\/doi.org\/10.3390\/cancers18152383","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]}}}